NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA

NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA was reported 31 times

NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD30-directed Immunoconjugate [EPC] 2 0.0002
1 Alkylating Drug [EPC] 7 0.0000
2 CD20-directed Cytolytic Antibody [EPC] 9 0.0000
3 Topoisomerase Inhibitor [EPC] 2 0.0000
4 Interleukin-23 Antagonist [EPC] 2 0.0000
5 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
6 Integrin Receptor Antagonist [EPC] 1 0.0000
7 Interleukin-12 Antagonist [EPC] 1 0.0000
8 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
9 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
10 Thalidomide Analog [EPC] 3 0.0000
11 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
12 Expectorant [EPC] 1 0.0000
13 Thiazide Diuretic [EPC] 1 0.0000
14 Platinum-based Drug [EPC] 1 0.0000
15 Vitamin D [EPC] 1 0.0000
16 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
17 Vitamin B12 [EPC] 1 0.0000
18 Vitamin C [EPC] 1 0.0000
19 Corticosteroid [EPC] 3 0.0000
20 Loop Diuretic [EPC] 1 0.0000